Read on Twitter
Thread on Outset Medical, potentially the next Nanox-style company to trade: Not a single person is Pounding the Table on this company... yet, I am happy to be the first and share what I found with you. Nanox ($NNOX) was an absolutely stunning IPO, running 230% in just 3 weeks...
... The theme here is revolutionizing the outdated healthcare space that costs providers, the government, and regular Americans so much everyday of every year. In the next 10 years, the healthcare space will be completely transformed through advancements in technology...
... It’s very clear to me this space will be one of the largest and fastest growing areas of the next decade. The reason Nanox was so clear to me was it revolutionized an old system integral to healthcare that hasn’t been updated in decades...
...Outset Medical ($OM) aims to do just that as well, in a space three times as big as Nanox spending wise. Outset Medical is a pioneering medical technology company reimagining dialysis for patients and health care providers...
... Outset has created Tablo, an at home, low-cost dialysis machine with an intuitive touchscreen interface that combined sensor-based automation designed to enhance the patient experience....
... It does this by accelerating the training process for patients (most only need 4-7 days to completely do it from memory), reducing treatment set up time, and streamlining the treatment process at home....
... Their four-wheel system only needs an electrical outlet and tap water connection to automatically produce daily stats required for dialysis. It includes a wireless cloud connection to monitor data. Older systems require separate equipment for purifying water and creating...
...dialysate, plus a number of manual steps to complete treatment. The IPO is set to be priced at a 790 million valuation. Their estimated revenue for this year is $63.8 million, up from just $15 million last year total. There are also pushes by the administration...
... By 2025, Trump wants 80% of people newly diagnosed with kidney failure to receive at home dialysis, according to an executive order issued in July. Currently, more than 85% of such patients are treated at dialysis centers outside of their home....
...In fact, the administration has already given Tablo a nod. The U.S. Department of Health and Human Services and in collaboration with the NY State Department of Health recently deployed 50 Tablo systems to hospitals in NYC and Long Island....
.... This already has FDA approval for their at-home system’s use. The only real competitor is NX stage, a 15 year old company way behind in tech that is being kicked to the curb by Tablo from all physician reports I’ve read. This could be a grand slam if it does...
... Not open too high. This is a $114 billion dollar industry a year in the US set to transition to being done “at home.” They are the best in tech, and the shift will happen. The IPO is set to open today between $22-24. I can’t wait!
